1. Introduction {#sec0005}
===============

Animal feeds are frequently contaminated with various mycotoxins produced by the secondary metabolism of diverse fungal contaminants in response to stress [@bib0215]. Among them, *Fusarium* spp. are the most prevalent mycotoxin producing fungi in temperate regions [@bib0220]. Trichothecenes, including deoxynivalenol (DON) and T-2 toxin, zearalenone and fumonisin B1, are toxicologically significant *Fusarium* spp. mycotoxins [@bib0225]. DON, also known as vomitoxin, is the most prevalent mycotoxin in grain [@bib0230] and because of the high percentage of cereal in pig diets, swine are frequently exposed to this toxin. In this animal, dietary concentrations between 2 and 5 mg DON/kg are associated with feed refusal and reduced weight gain, whereas concentrations over 20 mg DON/kg cause abdominal distress, diarrhea, vomiting and even shock or death [@bib0235]. High contamination levels are rare in modern agricultural practice, instead chronic exposure to low doses of DON is more frequent [@bib0240]. DON possesses also immunomodulatory properties [@bib0245]; in mouse, low concentrations exert pro-inflammatory effects by inducing cytokines and chemokines expression in mononuclear phagocytes, as a consequence of mitogen-activated protein kinases (MAPK) activation [@bib0250]. In the same model, dietary exposure to DON upregulates serum IgA and leads to decreased serum concentrations of IgM and IgG [@bib0255]. In pigs, DON has also been shown to activate MAPK in the intestine [@bib0260]. However, studies in primary porcine macrophages provide evidence for a lack of COX-2 and IL-6 activation by DON in this cell type, suggesting a distinct mode of action in this species [@bib0265]. Unlike mice, several investigations on pigs indicate only marginal or no effects of DON on IgA level [@bib0230]. Nonetheless, other studies reported an increase of specific-IgA accompanied with a decrease of specific IgG and cytokines activation following immunization with ovalbumin in DON-fed piglets [@bib0270], [@bib0275]. More recently, DON naturally contaminated diet has also been shown to decrease porcine reproductive and respiratory syndrome (PRRS) virus-specific antibody responses following experimental infection [@bib0280].

Economically, PRRS is the most important viral disease in swine livestock worldwide [@bib0285]. Causative agent of PRRS is a small enveloped positive-sense single-stranded RNA virus classified in the order *Nidovirales*, family *Arteriviridae*, genus *Arterivirus*, which also includes lactate dehydrogenase-elevating virus of mice, simian hemorrhagic fever virus and equine arteritis virus [@bib0290]. PRRSV causes common clinical signs such as anorexia, fever, and lethargy. In sows, PRRSV is responsible for reproductive failure, characterized by late-term abortions, increased numbers of stillborn fetuses, and/or premature, weak pigs. Furthermore, PRRSV is responsible for respiratory problems in growing and finishing pigs [@bib0295], [@bib0300]. Measures currently used to control PRRS include management practices such as whole herd depopulation/repopulation or herd closure, constraining bio-security measures, surveillance of herd status and vaccination [@bib0305]. Modified live vaccines (MLV) against PRRSV have been widely used and have shown some efficacy in reducing clinical disease severity, as well as viremia duration and virus shedding [@bib0310]. Given the impact of DON on the pig immune response and wide spread use of PRRS MLV vaccine for the control of this economically devastating disease, the objective of this study was to determine the effect of DON naturally contaminated feed on the immune response generated following vaccination with PRRS MLV.

2. Materials and methods {#sec0010}
========================

2.1. Animals {#sec0015}
------------

The experiment was conducted at the Faculté de médecine vétérinaire, Université de Montréal. Animal care procedures followed the guidelines of the Canadian Council on Animal Care and the protocol was approved by the institutional animal care committee (Protocol \#14-Rech-1751). Eighteen commercial crossbred piglets, PCR and serum-negative for PRRSV were purchased locally at 4 weeks of age. After one week of acclimation on a commercial ration, piglets were randomly divided into 3 experimental groups of 6 animals, housed separately and fed *ad libitum* naturally contaminated diets containing 0 (control diet), 2.5 or 3.5 mg/kg of DON for the duration of the experiment.

2.2. Experimental diets {#sec0020}
-----------------------

The experimental diets used in this study were formulated according to the energy and amino acid requirements for piglets as previously described [@bib0280]. Dietary contents of mycotoxins were analyzed in the final diet through ultra-performance liquid chromatography/electrospray ionization tandem mass spectrometry as previously described [@bib0280].

2.3. PRRSV vaccination {#sec0025}
----------------------

Before the beginning of the study, animals were weighed to assure the homogeneity of the experimental groups. No significant difference in body weight was found between experimental groups with a one-way ANOVA model using the parametric Tukey test (*P*  \> 0.05) (data not shown). After 1 week of acclimation with experimental diet, all animals were vaccinated intramuscularly (im) into the neck muscles using a 20~G~ 1 in. needle with Ingelvac^®^ PRRS MLV vaccine (lot \#245-F31) as recommended by the manufacturer (Boehringer Ingelheim Vetmedica, St. Joseph, MO, USA).

2.4. Body weight and blood collection {#sec0030}
-------------------------------------

Pigs were weekly monitored for body weight before vaccination and for 35 days post-vaccination (pv). Average daily gain (ADG) was calculated for each week of the experiment by subtracting the body weight from the previous week of the body weight at the measured time and divided by 7 days.

Blood samples were collected at days −1, 6, 13, 20, 27 and 35 pv to evaluate PRRSV viremia by RT-qPCR and to measure specific antibody response by ELISA. Serum samples were stored frozen at −80 °C for further analysis.

2.5. PRRSV quantification {#sec0035}
-------------------------

Sera were analyzed for the presence of PRRSV RNA viral genome using RT-qPCR assay as previously described [@bib0315]. QIAamp Viral RNA kit (Qiagen) was used to isolate viral RNA from serum samples according to the manufacturer\'s instructions. A commercial PRRSV RT-qPCR diagnostic kit (NextGen, Tetracore Inc., Gaithersburg, MD, USA) was used for PRRSV quantification as recommended by the manufacturer. The quantification of PRRSV was determined by comparing sample results with a standard curve based on the amount of serially diluted PRRSV IAF-Klop reference strain produced in MARC-145 cells and titrated as TCID~50~/mL in the MARC-145-infected cell [@bib0315]. The PRRSV RT-qPCR results were expressed in TCID~50~/mL of serum.

2.6. PRRSV specific antibodies {#sec0040}
------------------------------

Sera were assayed for virus-specific antibody by ELISA using the Herdchek PRRS X3 diagnostic kits (IDEXX Laboratories, Portland, Maine, USA). Serum were diluted 1/40 in a diluent supplied by the manufacturer and the assay was performed following the manufacturer\'s instructions. A sample-to-positive (S:P) ratio equal or greater than 0.4 was considered positive.

2.7. Virus neutralizing antibody titer {#sec0045}
--------------------------------------

Serum samples were heat inactivated (56 °C, 30 min) and serially diluted before the titration. The serial dilutions of serum samples were mixed with equal volume PRRSV VR-2332 vaccinal strain containing 100 TCID~50~ of the virus. After incubation at 37 °C for 2 h, the mixtures were transferred to MARC-145 monolayers in 96-well plates and incubated for an additional 72 h at 37 °C in a humidified atmosphere containing 5% CO~2~. Cells were then examined for cytopathic effects (CPE). CPE was used to determine the end-point titers that were calculated as the reciprocal of the highest serum dilution required to neutralize 100 TCID~50~ of PRRSV.

2.8. Statistical analysis {#sec0050}
-------------------------

Results are expressed as mean ± SEM. All statistical analyses were performed using GraphPad Prism software (version 5.03, GraphPad Prism software Inc., San Diego, CA). Data were statistically analyzed using a one-way ANOVA with Dunnett\'s multiple comparison test, using animal receiving control diet as control group. For PRRSV-specific antibody response, pair-wise mean comparisons between control and DON treated animals were made using Welch\'s unpaired *t* test. *P*  \< 0.05 was considered to reflect statistically significant differences.

3. Results {#sec0055}
==========

3.1. Growth performance {#sec0060}
-----------------------

ADG was evaluated each week of the experiment. DON naturally contaminated diet had no significant effect on ADG during the week prior to vaccination ([Fig. 1](#fig0005){ref-type="fig"} at day −1 post vaccination (dpv)). Results also showed that contaminated diet with DON at 3.5 mg/kg significantly decreased ADG (*P*  \< 0.05) after vaccination with a loss of 32%, 24%, 12% and 18% of kg/day at day 6, 13, 27 and 34, respectively, when compared to control group ([Fig. 1](#fig0005){ref-type="fig"}).Fig. 1Week by week average daily gain (ADG) before and after vaccination. ADG was calculated for each week of the experiment by subtracting pigs' body weights of the previous week with the body weight at the measured time and divided by 7 days. \* Indicates difference between DON fed groups and control for each time point (*P* *\<* 0.05), \*\* (*P* *\<* 0.01).

3.2. Viremia {#sec0065}
------------

Presence of PRRSV mRNA in sera was evaluated by RT-qPCR prior and after vaccination, at day −1, 6, 13, 20 pv. All piglets were PCR negative prior to vaccination (data not shown). All pigs fed control diet were viremic at day 6 pv, while none and 3 out of 6 pigs were viremic in the groups receiving 3.5 and 2.5 mg of DON/kg of the diet, respectively ([Fig. 2](#fig0010){ref-type="fig"}A). At day 13 pv, the viral burden was significantly lower (*P*  \< 0.05) in both groups fed DON-contaminated diets compared to the group fed control diet ([Fig. 2](#fig0010){ref-type="fig"}B). At day 20 pi, all piglets had very low PRRSV titers or were PCR negative and no significant differences were observed between experimental groups ([Fig. 2](#fig0010){ref-type="fig"}C).Fig. 2Effect of DON naturally contaminated diets on PRRSV viremia following vaccination with PRRS MLV vaccine. Blood was collected at day 6 (A), 13 (B), and 20 (C) pv and serum tested for the presence of PRRSV RNA by RT-qPCR. Data are expressed in TCID~50~/mL. \* Indicates difference between DON fed groups and control for each time point (*P* *\<* 0.05), \*\*\* (*P* *\<* 0.001).

3.3. Antibody response {#sec0070}
----------------------

Presence of PRRSV-specific IgG was evaluated using a commercial ELISA kit (Herdcheck PRRS X3) at day −1, 13, 20, 27 and 34 pv. All piglets were serum-negative prior to vaccination (data not shown). At day 13 pv, 5 out of 6 pigs fed control diet had seroconverted, while none and 3 out of 6 pigs had seroconverted in groups receiving 3.5 and 2.5 mg of DON/kg of the diet, respectively ([Fig. 3](#fig0015){ref-type="fig"}A). Antibody titers were significantly higher (*P*  \< 0.05) in group fed control diet compared to the group fed DON-contaminated diet at 3.5 mg/kg for all evaluated days ([Fig. 3](#fig0015){ref-type="fig"}A--D). From day 27 pv, all pigs fed control diet developed PRRSV specific antibodies while only viremic pigs, i.e. 1 and 3 that were fed 3.5 and 2.5 mg of DON/kg of the diet respectively, developed PRRSV specific antibodies ([Fig. 3](#fig0015){ref-type="fig"}C and D).Fig. 3Effect of DON naturally contaminated diets on PRRS-specific antibody titer. Blood was collected at day (A) 13, (B) 20, (C) 27 and (D) 34 pv and sera were tested for the presence of specific PRRSV antibodies using a commercial ELISA kit (HerdChek-PRRS^®^, IDEXX). Data are expressed in sample to positive (S:P) ratio. S:P ratio equal or greater than 0.4 was considered positive. The dash bar represents value of negative--positive cut-off s/p ratio. \* Indicates difference between DON fed groups and control for each time point (*P* *\<* 0.05).

3.4. Neutralizing antibody response {#sec0075}
-----------------------------------

Presence of PRRSV-neutralizing antibodies was evaluated at day 34 pv, using a PRRSV microneutralizing assay in MARC-145 cells. Results showed that the majority (5 out of 6) of pigs fed control diet mounted a neutralizing antibody response compared to 1 and 3 in pigs fed 3.5 and 2.5 mg of DON/kg of the diet, respectively ([Fig. 4](#fig0020){ref-type="fig"} ). PRRSV-neutralizing antibody response was significantly lower in pigs fed DON-contaminated diet at 3.5 mg/kg.Fig. 4Effect of DON naturally contaminated diets on PRRSV neutralizing antibody titer. Blood was collected at day 34 pv and sera were tested for the presence of PRRSV neutralizing antibodies to VR-2332 strain. Data are expressed as reciprocal dilution titer. The dash bar represents the limit of detection. \* Indicates difference between DON fed groups and control (*P* *\<* 0.05).

4. Discussion {#sec0080}
=============

Contamination of cereal by mycotoxins produced by *Fusarium* spp. is a serious problem in animal nutrition worldwide, especially in pigs [@bib0320]. Main toxicological effects of DON-contaminated feed are decreased body weight gain and voluntary feed intake [@bib0325], [@bib0330]. Here, DON naturally contaminated feed had no significant impact on ADG prior to vaccination. Even though one other study, also showed no significant effect of DON on ADG [@bib0275], these results must be analyzed carefully because chronic effects of DON on ADG might be observed after 3 weeks of diet consumption [@bib0335]. However the ADG decreased significantly after vaccination in the group fed 3.5 mg/kg of DON. Decreased ADG in pig has also been observed soon after vaccination [@bib0340], [@bib0345]. The present results show that diets contaminated with DON interact with PRRS attenuated vaccine and increases the loss of weight gain after vaccination. Similar effects have been previously observed after experimental infection with PRRSV in pigs fed DON naturally contaminated diet [@bib0280].

PRRS MLV vaccine has shown some protective efficacy against PRRSV clinical disease induced by the strains that are genetically related to the vaccine [@bib0350]. However, this vaccine elicits relatively weak neutralizing antibody and cell-mediated immune responses. PRRSV-specific antibodies appear approximately two weeks, and peak around four weeks after vaccination [@bib0355]. The majority of the antibodies are directed against viral nucleocapsid proteins (N) which have no neutralizing activity [@bib0355]. Generation of neutralizing antibodies is delayed in PRRSV infection and usually appears three to four weeks after vaccination [@bib0360]. Typically, serum neutralizing antibody titers are unusually low in comparison to those induced by other viruses [@bib0310]. The present results showed that DON naturally contaminated feed significantly decreased the antibody response generated following PRRS MLV vaccination. Vaccine failures are not uncommon in the field [@bib0365] and can be virus related due to a lack of cross-protection between the vaccine and field strains [@bib0370], [@bib0375] or immune related due to inefficient immune response [@bib0380]. Here, PRRS vaccine failure appears to be caused by an inefficient immune response following the ingestion of feed naturally contaminated with DON. Indeed, contamination of feed with DON has been previously implicated in vaccine failure due to the effects of DON on the immune system [@bib0270], [@bib0385], [@bib0390]. Moreover, ingestion of DON naturally contaminated feed have been previously shown to decrease PRRSV-specific antibody titers after experimental PRRSV infection [@bib0280]. In the case of PRRS MLV, live PRRSV replication is required to provide immunological protection against PRRSV infection [@bib0395]. The present results showed that ingestion of DON at different concentrations (2.5 and 3.5 mg/kg) severely decreases the replication of the attenuated vaccine strain in vaccinated pigs. This suggests that the effect of DON on the immune response generated by the MLV vaccine is more related to its impact on the replication of vaccinal virus in swine. DON has been shown previously to inhibit PRRSV replication in MARC-145 and porcine alveolar macrophages (PAM) cell models [@bib0400]. In that study, it was suggested that the early activation of pro-inflammatory genes and apoptosis following DON exposure was detrimental to PRRSV replication. In studies with concomitant viral infections, previous porcine respiratory coronavirus (PRCV) [@bib0405] and porcine circovirus type 2 (PCV2) [@bib0410], two potent inducer of endogenous IFN, have also been shown to decrease significantly PRRSV replication following experimental infection. Involvement of pro-inflammatory genes in the inhibition of PRRSV replication following DON-contaminated feed ingestion remains to be determined.

In conclusion, the present study showed for the first time an adverse effect of DON naturally contaminated feed on the immune response generated by a modified live vaccine. Live viral vaccines are among the most effective strategies for the induction of lifelong immunity and many of these vaccines are routinely used to provide protection against many human [@bib0415] and animal viral diseases [@bib0420]. It is difficult to predict if the present findings can be applied to other live viral vaccine, because of the small size of groups used in this study but also the impact of DON-contaminated feed might be virus-specific. In the particular case of PRRS vaccine, the immune response was blunted by an impairment of virus replication following ingestion of DON-contaminated feed. Further studies are needed to describe the exact mechanism by which DON-contaminated feed impairs the replication of PRRSV vaccinal strains.
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